AMH Equity Ltd Makes New $703,000 Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

AMH Equity Ltd bought a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 110,000 shares of the construction company's stock, valued at approximately $703,000. AMH Equity Ltd owned 0.13% of Aspen Aerogels as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Millennium Management LLC raised its holdings in shares of Aspen Aerogels by 4,757.8% in the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock worth $19,270,000 after purchasing an additional 1,588,632 shares in the last quarter. Point72 Asset Management L.P. bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $13,122,000. Alyeska Investment Group L.P. bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $9,504,000. Dendur Capital LP acquired a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $9,207,000. Finally, Renaissance Technologies LLC raised its holdings in shares of Aspen Aerogels by 472.4% during the fourth quarter. Renaissance Technologies LLC now owns 766,400 shares of the construction company's stock valued at $9,105,000 after acquiring an additional 632,500 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have commented on ASPN. Oppenheimer downgraded shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Barclays reaffirmed an "equal weight" rating and set a $7.00 price objective (down from $13.00) on shares of Aspen Aerogels in a report on Thursday, May 29th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $18.44.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young bought 20,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was acquired at an average cost of $5.35 per share, with a total value of $107,000.00. Following the transaction, the chief executive officer directly owned 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This represents a 3.77% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.40% of the company's stock.

Aspen Aerogels Stock Up 5.5%

Shares of NYSE ASPN traded up $0.41 during midday trading on Tuesday, reaching $7.80. The company's stock had a trading volume of 2,748,235 shares, compared to its average volume of 2,047,429. The company has a current ratio of 4.22, a quick ratio of 3.53 and a debt-to-equity ratio of 0.40. Aspen Aerogels, Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $33.15. The stock has a market capitalization of $640.05 million, a price-to-earnings ratio of -2.23 and a beta of 2.65. The stock has a 50 day simple moving average of $6.22 and a 200-day simple moving average of $7.54.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The business had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a negative net margin of 65.47% and a positive return on equity of 6.69%. The firm's revenue for the quarter was down 16.7% on a year-over-year basis. During the same period in the previous year, the company earned ($0.02) earnings per share. Equities research analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.